The purpose of this study is to implement a clinic-level cancer survivorship care delivery intervention in partnership with community health center clinicians, patients, and community representatives to test effectiveness of the intervention to improve patient and clinician outcomes and to evaluate implementation of the intervention using an iterative, concurrent mixed-methods approach guided by the Practice Change Model.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
5,584
Guided by the Practical, Robust Implementation and Sustainability Model (PRISM), the intervention includes three evidence-based components: 1. Training: This will include provider-to-provider tele-mentoring using Enhancing Community Health Outcomes (ECHO). 2. Tracking: This includes systematically assessing cancer history and monitoring survivors' care to plan and organize subsequent care. 3. Coordinating care for cancer survivors. Each clinic leader will designate a staff member (or members) as the care coordinator champion after exploring current clinic staff, skills, and capacity of various staff roles.
The University of Texas Health Science Center, Houston
Houston, Texas, United States
Proportion of eligible cancer survivors screened for second primary cancers
Data derived from electronic health records
Time frame: every 6 months from baseline to end of study (about 36 months from baseline)
Change in proportion of primary care clinician knowledge of cancer survivorship care
Assessed by self-administered survey
Time frame: baseline, six months following end of intervention period
Change proportion of survivors that report better experience of provider communication as assessed by the adapted Consumer Assessment of Healthcare Providers and Systems (CAHPS 4.0)
Time frame: baseline, six months following end of intervention period
Change proportion of survivors that report better experience of care coordination as assessed by the adapted Consumer Assessment of Healthcare Providers and Systems (CAHPS 4.0)
Time frame: baseline, six months following end of intervention period
Proportion of survivors who received guideline-recommended surveillance for the most prevalent cancers (breast colorectal, prostate, cervical, and lung)
Per national guidelines \[National Comprehensive Cancer Network (NCCN), U.S. Preventive Services Task Force (USPSTF)\]; data derived from electronic health records
Time frame: every 6 months from baseline to end of study (about 36 months from baseline)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.